Abraxis Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABRAXIS PHARM, and what generic and branded alternatives to ABRAXIS PHARM drugs are available?
ABRAXIS PHARM has one hundred and thirteen approved drugs.
Summary for Abraxis Pharm
| US Patents: | 0 |
| Tradenames: | 63 |
| Ingredients: | 60 |
| NDAs: | 113 |
Drugs and US Patents for Abraxis Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | METRONIDAZOLE | metronidazole | INJECTABLE;INJECTION | 070071-001 | Dec 3, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abraxis Pharm | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 086761-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abraxis Pharm | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 089144-001 | Mar 28, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
